recipharm advanced bio

Private

Last Round

Take Private

Feb 15, 2021

Last Round Size

$2.28B

Est. Valuation

$3B

Total Funding Raised

$2.82B

Company Overview

A contract development and manufacturing organization (CDMO) focused on advanced therapy medicinal products (ATMPs).

Historical view of private secondary pricing and transaction trends.

Proprietary index based on bid/ask volume and sentiment.

Track how buyer interest and sentiment changes over time.

Related companies by embedding similarity.

Access detailed peer comparisons, multiples, and valuation benchmarks.

Historical fundraising activity

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SEC and related filings with document metadata.

Common questions about recipharm advanced bio's valuation, stock price, and market status.

Headquarters—

Year Founded2022

Last FundingFeb 15, 2021

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.